This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover various work from home opportunities that can provide you with fast money. These options cater to different skills and schedules.
19,997 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Jeff Bezos argues that artificial intelligence will drive new job demand and skills need, potentially creating a labo...
If you’re weighing AI investing options, two popular ETFs—CHAT and XLK—show two very different paths. This guide brea...
The space economy is heating up, and a few standout names could reshape portfolios. This article breaks down the best...
A bold shift from a traditional hotel operator to AI-focused opportunities helped Ackman fuel outsized gains. Here’s ...
Looking for tech stocks with staying power? This guide breaks down how to pick what best tech stocks to hold for the ...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
Rand Capital's Q1 2026 earnings set the tone for the year. This analysis breaks down the numbers, portfolio quality, ...
Andreessen Horowitz is tapping California’s pension funds for the first time, led by CalPERS’ $400 million commitment...
A major fund reshaped its Workiva stake in a recent SEC filing, signaling routine portfolio rebalancing rather than a...
The race to a cleaner power grid is accelerating. Projected annual global renewable energy investment could reach $2....
Choosing between VNQ and RWO isn’t just about geography. This guide breaks down how US-focused VNQ compares to global...